The Impact of B12 Vitamin and Folate Deficiency on Depression Levels in Breast Cancer Patients Impact of Vitamin B12 and Folic Acid Deficiency on Depression in Breast Cancer Patients
Article Sidebar
Main Article Content
Abstract
Objective: This study aims to investigate the impact of B12 vitamin and folate deficiency on depression levels in breast cancer patients.
Material and Methods: A total of 99 breast cancer patients were included in the study, and sociodemographic data, treatment information, and lifestyle factors were recorded. Depression levels were evaluated using the Beck Depression Inventory, and B12 and folate levels were measured through laboratory tests. Statistical analyses were performed using the SPSS software, and the Mann-Whitney U test was used.
Results: Patients who smoked and used alcohol had significantly higher depression scores (p=0.009 and p=0.028, respectively). Additionally, patients with low B12 vitamin levels had significantly higher depression scores (p=0.036). Similarly, patients with folate deficiency also had higher depression scores (p=0.015).
Conclusion: This study demonstrates that B12 and folate deficiency can increase depression levels in breast cancer patients. Correcting B12 and folate levels in the management of depression may help improve the quality of life and positively influence the treatment process. Regular monitoring of B12 and folate levels and providing necessary treatment and support are essential in clinical practice.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-09-20
Published 2023-09-22
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. DOI: https://doi.org/10.3322/caac.21492
Ganz PA. Psychological and social aspects of breast cancer. Oncology (Williston Park). 2008 May;22(6):642–6, 650; discussion 650, 653.
Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57–71. DOI: https://doi.org/10.1093/jncimonographs/lgh014
Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1103–12. DOI: https://doi.org/10.1016/j.pnpbp.2005.06.021
Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a comprehensive review. Am J Epidemiol. 2007 Jan 1;165(1):1–13. DOI: https://doi.org/10.1093/aje/kwj347
Reynolds EH. Folic acid deficiency and its neurological consequences. In 2014. p. 927–43. DOI: https://doi.org/10.1016/B978-0-7020-4087-0.00061-9
Ulusoy IS, Horasanli B, Kulaksizoglu S. The correlation between vitamin B12 and vitamin D levels and self-reported cognitive complaints in individuals with initial episode major depressive disorder. Dusunen Adam: The Journal of Psychiatry and Neurological Sciences. 2021;34:64-72. DOI: https://doi.org/10.14744/DAJPNS.2020.00121
Maunsell E, Brisson J, Deschênes L. Psychological distress following initial breast cancer treatment: Identifying potential risk factors. Cancer. 1992 Jul 1;70(1):120–5. DOI: https://doi.org/10.1002/1097-0142(19920701)70:1<120::AID-CNCR2820700120>3.0.CO;2-U
Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early-stage breast cancer: A five-year observational cohort study. BMJ. 2005 Mar 26;330(7493):702. DOI: https://doi.org/10.1136/bmj.38343.670868.D3
Holahan CJ, Moos RH, Holahan CK, Brennan PL. Social context, coping strategies, and depressive symptoms: An expanded model with cardiac patients. J Pers Soc Psychol. 1997 Apr;72(4):918–28. DOI: https://doi.org/10.1037/0022-3514.72.4.918
Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual well-being in women after a breast cancer diagnosis. J Clin Oncol. 1999 Aug;17(8):2371–80. DOI: https://doi.org/10.1200/JCO.1999.17.8.2371
Lorant V, Deliège D, Eaton W, Robert A, Philippot P, Ansseau M. Socio-economic disparities in depression: A meta-analysis. Am J Epidemiol. 2003 Jan 15;157(2):98–112. DOI: https://doi.org/10.1093/aje/kwf182
Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no prior history of depression. Arch Gen Psychiatry. 2006 Apr;63(4):375–82. DOI: https://doi.org/10.1001/archpsyc.63.4.375
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593–602. DOI: https://doi.org/10.1001/archpsyc.62.6.593